# OnCo record paper-royal-ipilimumab-pancreatic-j-immunother-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-royal-ipilimumab-pancreatic-j-immunother-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-royal-ipilimumab-pancreatic-j-immunother-2010" ;
  schema:name "Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma"@en ;
  schema:description "The first checkpoint inhibitor trial in pancreatic cancer gave ipilimumab to 27 patients and not one tumour shrank by the standard measure, though one patient regressed later after apparent progression."@en ;
  schema:url <https://onco.cc/key-papers/paper-royal-ipilimumab-pancreatic-j-immunother-2010/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1097/CJI.0b013e3181eec14c>, <https://pubmed.ncbi.nlm.nih.gov/20842054/> ;
  schema:sameAs <https://doi.org/10.1097/CJI.0b013e3181eec14c> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Royal RE, Levy C, Turner K, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/metastatic-pdac/>, <https://onco.cc/cancers/locally-advanced-pdac/> ;
  onco:targets <https://onco.cc/targets/ctla4/> ;
  onco:drugs <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/nci-ccr/> ;
  onco:pathways <https://onco.cc/pathways/pd1-checkpoint/> ;
  onco:terms <https://onco.cc/terms/cold-vs-hot/> .